Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | GSK4381562 |
Synonyms | |
Therapy Description |
GSK4381562 (SRF813) is a monoclonal antibody targeting CD112R (PVRIG), which potentially increases NK cell activation and inhibits tumor growth (Cancer Res 2020;80(16 Suppl):Abstract nr 4548). |